Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where KURA declined for three days, in 256 of 313 cases, the price declined further within the following month. The odds of a continued downward trend are 82%.
The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KURA as a result. In 63 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for KURA turned negative on September 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 30 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
KURA moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for KURA crossed bearishly below the 50-day moving average on September 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
The Aroon Indicator for KURA entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for KURA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +4.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where KURA advanced for three days, in 213 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
KURA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. KURA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.493) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (12.821) is also within normal values, averaging (437.542).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KURA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
RLAY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 08, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 38 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 53 cases where RLAY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RLAY as a result. In 78 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
RLAY moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RLAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for RLAY entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Following a +3.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where RLAY advanced for three days, in 238 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
RLAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. RLAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.355) is normal, around the industry mean (26.782). P/E Ratio (17.301) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (333.333) is also within normal values, averaging (437.542).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
KURA | RLAY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 64 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 97 | |
PRICE GROWTH RATING 1..100 | 57 | 38 | |
P/E GROWTH RATING 1..100 | 100 | 8 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
KURA's Valuation (64) in the Biotechnology industry is in the same range as RLAY (77) in the null industry. This means that KURA’s stock grew similarly to RLAY’s over the last 12 months.
KURA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RLAY (100) in the null industry. This means that KURA’s stock grew similarly to RLAY’s over the last 12 months.
RLAY's SMR Rating (97) in the null industry is in the same range as KURA (99) in the Biotechnology industry. This means that RLAY’s stock grew similarly to KURA’s over the last 12 months.
RLAY's Price Growth Rating (38) in the null industry is in the same range as KURA (57) in the Biotechnology industry. This means that RLAY’s stock grew similarly to KURA’s over the last 12 months.
RLAY's P/E Growth Rating (8) in the null industry is significantly better than the same rating for KURA (100) in the Biotechnology industry. This means that RLAY’s stock grew significantly faster than KURA’s over the last 12 months.
| KURA | RLAY | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 89% | N/A |
| Stochastic ODDS (%) | 1 day ago 79% | 1 day ago 85% |
| Momentum ODDS (%) | 6 days ago 79% | 1 day ago 86% |
| MACD ODDS (%) | 6 days ago 73% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 85% |
| Advances ODDS (%) | 27 days ago 80% | 3 days ago 86% |
| Declines ODDS (%) | 1 day ago 82% | 7 days ago 87% |
| BollingerBands ODDS (%) | 1 day ago 86% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 74% | 1 day ago 86% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KURA’s FA Score shows that 0 FA rating(s) are green while RLAY’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KURA’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 2 bullish TA indicator(s).
KURA (@Biotechnology) experienced а -6.65% price change this week, while RLAY (@Biotechnology) price change was -7.36% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -14.96%, and the average quarterly price growth was -16.57%.
KURA is expected to report earnings on Oct 29, 2026.
RLAY is expected to report earnings on Nov 11, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SEPT | 38.91 | 0.04 | +0.10% |
| AllianzIM U.S. Equity Buffer10 Sep ETF (SEPT) | |||
| SEPW | 34.21 | 0.01 | +0.03% |
| AllianzIM U.S. Equity Buffer20 Sep ETF (SEPW) | |||
| IBTH | 22.28 | N/A | +0.02% |
| iShares iBonds Dec 2027 Term Treasury ETF (IBTH) | |||
| RSPS | 29.76 | N/A | N/A |
| Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) | |||
| CBOA | 25.18 | N/A | N/A |
| Calamos Bitcoin Structured Alt Protection ETF - April | |||
A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.
| Ticker / NAME | Correlation To KURA | 1D Price Change % | ||
|---|---|---|---|---|
| KURA | 100% | -5.44% | ||
| XNCR - KURA | 53% Loosely correlated | -6.07% | ||
| IMVT - KURA | 53% Loosely correlated | -2.61% | ||
| KYTX - KURA | 50% Loosely correlated | -7.09% | ||
| DYN - KURA | 49% Loosely correlated | -4.14% | ||
| VIR - KURA | 48% Loosely correlated | -6.11% | ||
More | ||||
A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with KURA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then KURA could also see price increases.
| Ticker / NAME | Correlation To RLAY | 1D Price Change % | ||
|---|---|---|---|---|
| RLAY | 100% | -3.45% | ||
| KURA - RLAY | 47% Loosely correlated | -5.44% | ||
| CGEM - RLAY | 46% Loosely correlated | -5.69% | ||
| VCYT - RLAY | 44% Loosely correlated | -2.07% | ||
| AXON - RLAY | 42% Loosely correlated | -0.26% | ||
| KRRO - RLAY | 42% Loosely correlated | -5.98% | ||
More | ||||